Epidermal differentiation complex: A review on its epigenetic regulation and potential drug targets

Cell Journal

Volumn 18, Issue 1, 2016, Pages 1-6

  Abhishek, Sinha ^a   Krishnan, Suresh Palamadai ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Cornified Envelope; Differentiation; Drug Targeting; Keratinocyte; Proliferation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANNONA MURICATA EXTRACT; BAF250A PROTEIN; BRG1 PROTEIN; BRM PROTEIN; HISTONE; HISTONE ACETYL TRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; LUTEOLIN; MICRORNA; OLEANOLIC ACID; PROTEIN; QUERCETIN; ROMIDEPSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VORINOSTAT;

CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME 1Q; DNA METHYLATION; DRUG TARGETING; EPIDERMIS; EPIGENETICS; GENE CLUSTER; GENE CONTROL; HUMAN; NEOPLASM; PSORIASIS; REVIEW; SEBACEOUS GLAND;

EID: 84964957445     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009; 10(3): 207-217.
2. Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest. 2006; 116(5): 1150-1158.
3. Suga H, Sugaya M, Miyagaki T, Ohmatsu H, Kawaguchi M, Takahashi N, et al. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma. Clin Cancer Res. 2014; 20(16): 4339-4348.
4. Kypriotou M, Huber M, Hohl D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the fused genes family. Exp Dermatol. 2012; 21(9): 643-649.
5. Henry J, Toulza E, Hsu CY, Pellerin L, Balica S, Mazereeuw-Hautier J, et al. Update on the epidermal differentiation complex. Front Biosci (Landmark Ed). 2012; 17: 1517-1532.
6. Markova NG, Marekov LN, Chipev CC, Gan SQ, Idler WW, Steinert PM. Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol. 1993; 13(1): 613-625.
7. Mardaryev AN, Gdula MR, Yarker JL, Emelianov VU, Poterlowicz K, Sharov AA, et al. p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells. Development. 2014; 141(1): 101-111.
8. Wang M, Yue Z, Paus R, Ramot Y. SIRT2 as a new player in epigenetic programming of keratinocyte differentiation and a candidate tumor suppressor. Exp Dermatol. 2014; 23(9): 636-638.
9. Burnworth B, Popp S, Stark HJ, Steinkraus V, Bröcker EB, Hartschuh W, et al. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene. 2006; 25(32): 4399-4412.
10. Indra AK, Dupé V, Bornert JM, Messaddeq N, Yaniv M, Mark M, et al. Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation. Development. 2014; 132(20): 4533-4544.
11. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, Rapisarda V, et al. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol. 2011; 194(6): 825-839.
12. Bao X, Tang J, Lopez-Pajares V, Tao S, Qu K, Crabtree GR, et al. ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4. Cell Stem Cell. 2013; 12(2): 193-203.
13. Kashiwagi M, Morgan BA, Georgopoulos K. The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development. 2007; 134(8): 1571-1582.
14. LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, et al. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell. 2010; 19(6): 807-818.
15. Robertson ED, Weir L, Romanowska M, Leigh IM, Panteleyev AA. ARNT controls the expression of epidermal differentiation genes through HDAC-and EGFR-depend ent pathways. J Cell Sci. 2012; 125(Pt 14): 3320-3332.
16. Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G, et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell. 2009; 136(6): 1122-1135.
17. Luis NM, Morey L, Mejetta S, Pascual G, Janich P, Kuebler B, et al. Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and-independent functions of Cbx4. Cell Stem Cell. 2011; 9(3): 233-246.
18. Sen GL, Reuter JA, Webster DE, Zhu L, Khavari PA. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature. 2010; 463(7280): 563-567.
19. Roberson ED, Liu Y, Ryan C, Joyce CE, Duan S, Cao L, et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol. 2012; 132(3 Pt 1): 583-592.
20. Zhang P, Zhao M, Liang G, Yin G, Huang D, Su F, et al. Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J Autoimmun. 2013; 41: 17-24.
21. Mejetta S, Morey L, Pascual G, Kuebler B, Mysliwiec MR, Lee Y, et al. Jarid2 regulates mouse epidermal stem cell activation and differentiation. EMBO J. 2011; 30(17): 3635-3646.
22. Sen GL, Webster DE, Barragan DI, Chang HY, Khavari PA. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev. 2008; 22(14): 1865-1870.
23. Chen W, Xiao Liu Z, Oh JE, Shin KH, Kim RH, Jiang M, et al. Grainyhead-like 2 (GRHL2) inhibits keratinocyte differentiation through epigenetic mechanism. Cell Death Dis. 2012; 3: e450.
24. Driskell I, Oda H, Blanco S, Nascimento E, Humphreys P, Frye M. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin. EMBO J. 2012; 31(3): 616-629.
25. Nissan X, Denis JA, Saidani M, Lemaitre G, Peschanski M, Baldeschi C. miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification. Dev Biol. 2011; 356(2): 506-515.
26. Jackson SJ, Zhang Z, Feng D, Flagg M, OLoughlin E, Wang D, et al. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development. 2013; 140(9): 1882-1891.
27. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, et al. miR-203 represses 'stemness by repressing DeltaNp63. Cell Death Differ. 2008; 15(7): 1187-1195.
28. Sonkoly E, Wei T, PavezLoriè E, Suzuki H, Kato M, Törmä H, et al. Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J Invest Dermatol. 2010; 130(1): 124-134.
29. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007; 2(7): e610.
30. Viticchiè G, Lena AM, Cianfarani F, Odorisio T, Annicchiarico-Petruzzelli M, Melino G, et al. MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis. 2012; 3: e435.
31. Guinea-Viniegra J, Jiménez M, Schonthaler HB, Navarro R, Delgado Y, Concha-Garzón MJ, et al. Targeting miR-21 to treat psoriasis. Sci Transl Med. 2014, 6(225): 225re1.
32. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013; 493(7431): 231-235.
33. Botchkarev VA, Gdula MR, Mardaryev AN, Sharov AA, Fessing MY. Epigenetic regulation of gene expression in keratinocytes. J Invest Dermatol. 2012; 132(11): 2505-2521.
34. Marks PA. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim Biophys Acta. 2010; 1799(10-12): 717-725.
35. Paris M, Porcelloni M, Binaschi M, Fattori D. Histone deacetylase inhibitors: from bench to clinic. J Med Chem. 2008; 51(6): 1505-1529.
36. McLaughlin F, La Thangue NB. Histone deacetylase inhibitors in psoriasis therapy. Curr Drug Targets Inflamm Allergy. 2004; 3(2): 213-219.
37. Tiffon C, Adams J, van der Fits L, Wen S, Townsend P, Ganesan A, et al. The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. Br J Pharmacol. 2011; 162(7): 1590-1602.
38. George VC, Naveen Kumar DR, Suresh PK, Kumar S, Kumar RA. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev. 2013; 14(2): 631-637.
39. Chowdhury AR, Sharma S, Mandal S, Goswami A, Mukhopadhyay S, Majumder HK. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J. 2002; 366(Pt 2): 653-661.
40. Cantero G, Campanella C, Mateos S, Cortés F. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagenesis. 2006; 21(5): 321-325.
41. George VC, Kumar DR, Suresh PK, Kumar RA. Apoptosis-induced cell death due to oleanolic acid in HaCaT keratinocyte cells - A proof-of-principle approach for chemopreventive drug development. Asian Pac J Cancer Prev. 2012; 13(5): 2015-20.
42. George VC, Kumar DR, Rajkumar V, Suresh PK, Kumar RA. Quantitative assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. in normal and immortalized human cell lines. Asian Pac J Cancer Prev. 2012; 13(2): 699-704.
43. Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics. 2015; 7(1): 64.